Needham analyst Alex Henderson downgrades Varonis Systems (NASDAQ:VRNS) from Buy to Hold.
PhaseBio Announces Successful Pre-BLA Meeting With U.S. FDA For Bentracimab
PhaseBio recently received formal written minutes from the FDA following its Pre-BLA Meeting held in early April and is expecting to submit its Biologics License Application (BLA) by early in the fourth quarter of
